Interestingly, CDK12 plays distinguishing roles among various subtypes of breast cancer, especially for HER2 (human epidermal growth factor receptor 2)-positive breast cancer and triple-negative breast cancer (TNBC). This evidence concerns the gene ERBB2 and breast carcinoma.